Vertex’s 3-year feud with NICE is about to come to a head as CEO Leiden heads to London
Vertex’s legendary showdown with the NIH over marketing its cystic fibrosis drug Orkambi in the UK is about to shine a bright spotlight on CEO Jeff Leiden.
Leiden and commercial chief Stuart Arbuckle are headed to London to be questioned on Thursday by members of the UK’s Health and Social Care Committee, which is trying to see how the 3-year feud can be resolved, according to an update from PMLive.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
